Xilio Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Xilio Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Xilio Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Xilio Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $58 | 106 | 0.55 |
| 2023-09-30 | $211 | 100 | 2.11 |
| 2023-06-30 | $212 | 81 | 2.62 |
| 2022-12-31 | $206 | 77 | 2.69 |
| 2022-09-30 | $0 | 75 | 0.00 |
| 2022-06-30 | $0 | 51 | 0.00 |
| 2022-03-31 | $12k | 1.7k | 7.22 |
| 2021-12-31 | $71k | 4.5k | 15.91 |